RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF

Conditions:   Hepatitis B;   Acute-On-Chronic Liver Failure Interventions:   Other: Plasma exchange;   Other: RL-1 Novel Human-derived Bio-artificial Liver Treatment Sponsor:   Third Affiliated Hospital, Sun Yat-Sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials